{"name":"iRenix Medical, Inc.","slug":"irenix-medical-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Neuroscience","slug":"neuroscience","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"IRX-101","genericName":"IRX-101","slug":"irx-101","indication":"Chronic inflammatory demyelinating polyneuropathy (CIDP)","status":"phase_3"}]},{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Providone-Iodine","genericName":"Providone-Iodine","slug":"providone-iodine","indication":"Skin antisepsis and wound disinfection","status":"marketed"}]}],"pipeline":[{"name":"IRX-101","genericName":"IRX-101","slug":"irx-101","phase":"phase_3","mechanism":"IRX-101 is an intravenous immunoglobulin (IVIG) formulation designed to modulate immune responses and reduce inflammation.","indications":["Chronic inflammatory demyelinating polyneuropathy (CIDP)"],"catalyst":""},{"name":"Providone-Iodine","genericName":"Providone-Iodine","slug":"providone-iodine","phase":"marketed","mechanism":"Povidone-iodine is an antiseptic that releases iodine to kill microorganisms by oxidizing their cellular components.","indications":["Skin antisepsis and wound disinfection","Oral and throat antisepsis","Vaginal antisepsis","Preoperative skin preparation"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxPQzlSb0gtZ3U4TElPYVF1N01Md3VlZ0QtZ240Y3dpNk94UkhXUWVhWUVNOVRQWnZqWGZDM1M0eE9lNUVtWU5jck94NVl2Mk44Q0cxdFBUYjU2MENLWjQ5LVI5UmdMczc2YW9nRWZSdjRSM3RUdE5URkV2MmVxdFBFSDBQZGtXaUpVbVVieG01QTRoQ0E1VVNWYzdldlVOQjQ5TlJjeWFkaEdoTFpXNjZtNmVWa1ZPUGZaOVZQb29EVUJxNm1XZlpwSWpwWQ?oc=5","date":"2025-08-01","type":"pipeline","source":"Managed Healthcare Executive","summary":"Investigational Eye Antiseptic Shows Promise in Enhancing Patient Comfort | ASRS 2025 - Managed Healthcare Executive","headline":"Investigational Eye Antiseptic Shows Promise in Enhancing Patient Comfort | ASRS 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi8wFBVV95cUxQQVpld2hXNUhFTEptcm1MZVJFellnal9IWVo5Mjd1UkVRb0tVY0pxV2hvSDd2Y2ZGZ0xXNU9zTDY4eGFjNEI5R1JuTmdmUW9WYldWM2pMekdKVE9jNXRmOUx6a25XUlNLQ241dnhGVnZTLWFscG5GbmRUbzJ0RkhWMEN0NzhfSk92MWl0OU9QWDlCUVJ0VXduWFl2NndMRTFNNkU1bU5KdU56QTVfbktBNU0zYURhblZCTEVZZDhiSGxFWEhtUlRyY1F3bTdrTC0ybTZmU05lWTd2clNvQThmYUtpRjhGZHF0bWl6cXVwYlNyWFU?oc=5","date":"2024-04-09","type":"regulatory","source":"PR Newswire","summary":"Corneal Edema Therapeutics Market to Grow Significantly at a CAGR of 8.54% in the US by 2034 | DelveInsight - PR Newswire","headline":"Corneal Edema Therapeutics Market to Grow Significantly at a CAGR of 8.54% in the US by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxPb3NCYWJWYWxNSjFjN3RDVWE0QW85R0lHakdwMS1BY28yVzQtbW1QQnRXQjJybEJvTEJ0eHBzc1NOYXl6eUc2QVVOMzA1U3pIb0lEM0RsU2EtSk1TWXYzRnZYbTE2WU1DOHd6UFg1dmRqQ0tpbVhqSHJDZHFYNWdPUXNRdmR2Nmx2YzVhT0FfTXphWlhVYU1XM2V0Ym9xV0Fj?oc=5","date":"2021-02-01","type":"pipeline","source":"Ophthalmology Times","summary":"Tool offers ultra-rapid cooling for intravitreal injections - Ophthalmology Times","headline":"Tool offers ultra-rapid cooling for intravitreal injections","sentiment":"neutral"}],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":1,"marketed":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}